Attovia Therapeutics
Fremont, CA
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.
attovia.comCompany Details
Founded
- 2023
Employees
- Between 20 - 50 employees
Raised
- $165,000,000
Headquarters Location
- Fremont, CA
Public
- No
Acquired
- No
CEO
- Tao Fu
Founders
- David King
Company Collections
These are collections Attovia Therapeutics is a part of. Click on the collection name to view similar companies.